Ruben de Francisco, founder and CEO of Onera Health, added: “This validation is a critical milestone in our mission to make the gold-standard sleep test, polysomnography or PSG, available at the ...

The Global Ambulatory Polysomnography (PSG) Systems Market, valued at approximately USD 346.6 million in 2022, is anticipated to grow at a moderate CAGR of more than 1.5% during the forecast period ...

Objectives: To monitor preterm infants in a cot and a car seat and compare an observed car seat trial with polysomnography (PSG). Design: Non-randomised controlled trial. Setting: Regional neonatal ...

In what the company is calling one of the largest sleep diagnostic trials of the decade, (NCT05310708) Onera found its Sleep Test System (STS) to be comparable to the industry standard of in-lab ...

performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection. This press release features multimedia. View the full release here ...

performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection. The international multicenter study was managed by an independent Clinical ...

A board-certified sleep medicine specialist reviews the history of wearable sleep trackers and explains how clinicians ...

The study demonstrated that the patch-based Onera STS home-polysomnography (hPSG) performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event ...